Beam Therapeutics Inc. (BEAM)
NASDAQ·Healthcare·Biotechnology
$27.75
+7.06%
Mkt Cap $2.58B
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (19 analysts)
$52.00
Range $26.00 – $80.00
Implied Upside
+87.4%
Consensus $52.00 vs current $27.75
NASDAQ·Healthcare·Biotechnology
$27.75
+7.06%
Mkt Cap $2.58B
Buy
5
Hold
0
Sell
0
Price Target (19 analysts)
$52.00
Range $26.00 – $80.00
+87.4%
Consensus $52.00 vs current $27.75